Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 24, 2026

Multipotent Mesenchymal Stromal Cells - A Promising Cytotherapeutic Agent for Breast Cancer.

View Full Paper
Ask AI
Bookmark
Share

Authors

SSSankaranarayanan SrinivasanNGNalinkanth Veerabadran GhoneHJHariharan Jayaraman

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Srinivasan et al. (2026) studied this question.

synapsesocial.com/papers/6975659fd5e0d64addde7955https://doi.org/10.2174/011574888x398024250926100803
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1DEVELOPMENT OF STEM CELL-BASED CANCER THERAPY STRATEGIES2024
  2. 2Next-generation approaches for mesenchymal stem cell characterization and therapeutic application2025 · 1 citations
  3. 3From bench to bedside: translating mesenchymal stem cell therapies through preclinical and clinical evidence2025 · 44 citations
  4. 4Therapeutic potential of mesenchymal stem cell exosomes for tumors in the digestive system: From bench to bedside2025
  5. 5Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities2025 · 16 citations